Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125768) titled 'Efficacy and safety of indobufen, aspirin, cilostazol and clopidogrel in the treatment of ischemic stroke: a single center, retrospective study' on May 31.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Southern Medical University Southern Hospital
Condition:
Ischemic stroke
Intervention:
Aspirin group:None
Indobufen group:None
Cilostazol group:None
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-06-01
Target Sample Size: Aspirin group:500;Indobufen group:500;Cilostazol group:500;Clopidogrel group:500;
Countries of Recruitmen...